Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18-64 Years During the 2019-2020 US Influenza Season.

Mahrukh ImranJuan Puig-BarberaJustin R OrtizLorena Lopez-GonzalezAlex DeanMachaon BonafedeMendel Haag

Published in: Open forum infectious diseases (2023)

This real-world study conducted for the 2019-2020 season demonstrated that vaccination with IIV4c was associated with fewer cardiorespiratory, respiratory, and influenza hospitalizations compared with IIV4e.

Keyphrases

body composition
randomized controlled trial
high intensity
systematic review
single cell
cell therapy